Great Ormond Street Hospital NHS Foundation Trust (GOSH) confirms Epic Systems Corporation as preferred supplier for its electronic patient record (EPR) system and Aridhia Informatics Limited as preferred supplier for the research and innovation platform.
On Wednesday 25 January, details of two patients successfully treated for their leukaemia at Great Ormond Street Hospital using gene-editing technology were published in the journal, Science Translational Medicine.
Injecting cells from pregnant women could have a life-changing effect on the millions who are living with osteoporosis and brittle bone disease according to researchers at the UCL GOS Institute of Child Health, the research partner of Great Ormond Street Hospital and The UCL Institute for Women’s Health. These cells could also be useful for strengthening the fragile bones of astronauts during their stay for long periods in space.
Researchers from the UCL Great Ormond Street Institute of Child Health have discovered a new gene change that identifies a type of the movement disorder, muscle dystonia. This new discovery will allow doctors to more easily identify patients who can benefit from treatment so effective that it can restore the ability to walk.
Children with severe epilepsy who do not respond to traditional drugs could be treated with vitamin B6, after the discovery of a new gene by UCL Great Ormond Street Institute of Child Health (ICH) and its clinical partner Great Ormond Street Hospital (GOSH).
Leading Great Ormond Street Hospital (GOSH) clinician and pioneering researcher, Professor Francesco Muntoni, has won an EU staff award at the prestigious Health Service Journal (HSJ) Awards last night.
Great Ormond Street Hospital (GOSH) wins £3million for its world leading Somers Clinical Research Facility. This centre is a dedicated space for children from across the UK undergoing clinical treatment trials.